Drugs / GSK1399686
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00721812 | Sep 2008 → May 2009 | inflammatory bowel disease | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT01036022 | Sep 2009 → Jan 2013 | ulcerative colitis | GlaxoSmithKline | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK1399686 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01036022 ↗ |
| Route | Oral | “Repeated Oral Dosing in Healthy Volunteers” NCT00721812 ↗ |